Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure
- PMID: 23931878
- DOI: 10.1111/1744-9987.12085
Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure
Abstract
The kinetics of myoglobin in severe rhabdomyolysis and dialysis-dependent myoglobinuric acute kidney injury (Mb-AKI) is still not well elucidated, and more detailed knowledge could improve the now empiric use of rapid extracorporeal myoglobin removal by high cut-off (HCO) hemodialysis treatments. Eighteen adult patients with severe dialysis-dependent Mb-AKI (median serum concentration of myoglobin 57.4 mg/L) participated in the prospective clinical study, assessing myoglobin kinetics during HCO hemodiafiltration (HCO HDF). High initial serum concentrations of myoglobin (median 57.4 mg/L), together with protracted myoglobin appearance in the blood, indicated a large accumulation of myoglobin in body fluids. Extra-renal endogenous metabolic myoglobin clearance was delayed, with a slow exponential fall in serum myoglobin (t½ 35 h). A mean myoglobin clearance of 90-94 mL/min, a reduction ratio of 80%, and a rapid exponential fall (t½ 1 h) in serum and dialysate myoglobin were achieved by HCO HDF. Half of the cumulative myoglobin removal was accomplished in 3-5 h, with an additional removal of 7% each hour thereafter. A 2.4-fold rebound in serum myoglobin followed the HCO procedures. Large amounts of myoglobin are released into the circulation, and its endogenous metabolic clearance in dialysis-dependent Mb-AKI is slow. Owing to its rapid and highly efficient myoglobin elimination, HCO HDF may represent a valuable tool in the initial management of severe Mb-AKI, with a potential for earlier application in the future.
Keywords: Acute renal failure; Hemodiafiltration; High cut-off; Kinetics; Myoglobin.
© 2013 The Authors. Therapeutic Apheresis and Dialysis © 2013 International Society for Apheresis.
Similar articles
-
High cut-off membrane hemodiafiltration in myoglobinuric acute renal failure: a case series.Ther Apher Dial. 2011 Jun;15(3):287-91. doi: 10.1111/j.1744-9987.2011.00953.x. Ther Apher Dial. 2011. PMID: 21624078
-
High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series.Nephron Clin Pract. 2012;121(3-4):c159-64. doi: 10.1159/000343564. Epub 2013 Jan 16. Nephron Clin Pract. 2012. PMID: 23327834
-
Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury.Ther Apher Dial. 2013 Aug;17(4):391-5. doi: 10.1111/1744-9987.12084. Ther Apher Dial. 2013. PMID: 23931877
-
Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.Crit Care. 2014 May 28;18(3):224. doi: 10.1186/cc13897. Crit Care. 2014. PMID: 25043142 Free PMC article. Review.
-
[Rhabdomyolysis].Nihon Rinsho. 1991 Jun;49(6):1310-7. Nihon Rinsho. 1991. PMID: 1886217 Review. Japanese. No abstract available.
Cited by
-
Enhancing dialyser clearance-from target to development.Pediatr Nephrol. 2017 Dec;32(12):2225-2233. doi: 10.1007/s00467-017-3647-y. Epub 2017 Apr 12. Pediatr Nephrol. 2017. PMID: 28401301 Review.
-
The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis.Ren Fail. 2023;45(2):2259231. doi: 10.1080/0886022X.2023.2259231. Epub 2023 Sep 20. Ren Fail. 2023. PMID: 37728069 Free PMC article.
-
Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.Crit Care. 2020 Nov 11;24(1):644. doi: 10.1186/s13054-020-03366-8. Crit Care. 2020. PMID: 33176824 Free PMC article. Clinical Trial.
-
Extracorporeal myoglobin removal in severe rhabdomyolysis with high cut-off membranes-intermittent dialysis achieves much greater clearances than continuous methods.Crit Care. 2021 Mar 9;25(1):97. doi: 10.1186/s13054-021-03531-7. Crit Care. 2021. PMID: 33750390 Free PMC article. No abstract available.
-
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis.Crit Care. 2021 Jan 28;25(1):41. doi: 10.1186/s13054-021-03468-x. Crit Care. 2021. PMID: 33509234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous